Albalate Marta, de la Piedra Concepción, Fernández Cristina, Lefort Mar, Santana Henar, Hernando Paloma, Hernández Jesús, Caramelo Carlos
Fundación Renal Iñigo Alvarez de Toledo, Instituto Reina Sofía de Investigación Nefrológica, Universidad Autónoma, Madrid, Spain.
Nephrol Dial Transplant. 2006 Jun;21(6):1626-32. doi: 10.1093/ndt/gfl034. Epub 2006 Feb 20.
As the main mineral reservoir, bone acts as a calcium (Ca) and phosphate buffering system. Accordingly, phosphate removal by haemodialysis (HD) might be theoretically influenced by bone turnover, as well as by the interaction of regulatory molecules, such as PTH and osteoprotegerin (OPG). The present study investigated the relationship between these variables and phosphate removal by HD.
Blood samples for serum Ca, phosphate, bicarbonate, intact PTH, PTH (1-84), bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, OPG and receptor activator of nuclear factor-kappaB ligand (RANKL) were obtained in 28 HD patients. Phosphate removal was measured by a continuous collection of the dialysate.
Pre-dialysis serum phosphate concentration is the critical factor in determining dialytic phosphate removal. However, multiple regression analysis reveals that phosphate removal is better explained by a combination of factors than by phosphate concentration alone. In this model, the PTH/OPG ratio is an additional positive factor, whereas age and vitamin D treatment are negative factors. Patients with pre-HD bicarbonate higher than 20 mEq/l had higher serum phosphate and, accordingly, higher phosphate removal; of interest, these individuals also have significant differences in RANKL/OPG. Mean (SD) OPG levels were significantly higher than that in the healthy population (16.2 (12.5) pmol/l; these values correlated with age (r = 0.4, P<0.04). Mean serum RANKL (1.03 (1.02) pmol/l) was within the range of normal individuals.
Dialytic phosphate removal has a crucial, direct relationship with pre-HD plasma phosphate levels. However, the phenomenon of phosphate removal is more precisely explained using a more complex relationship, defined by the interaction between serum phosphate, PTH/OPG, age and vitamin D administration. Serum RANKL levels are first reported in HD patients, and are not different from the normal population.
作为主要的矿物质储存库,骨骼起着钙(Ca)和磷酸盐缓冲系统的作用。因此,理论上血液透析(HD)对磷酸盐的清除可能受骨转换以及甲状旁腺激素(PTH)和骨保护素(OPG)等调节分子相互作用的影响。本研究调查了这些变量与HD清除磷酸盐之间的关系。
采集了28例HD患者的血液样本,检测血清钙、磷酸盐、碳酸氢盐、完整PTH、PTH(1 - 84)、骨碱性磷酸酶、抗酒石酸酸性磷酸酶5b、OPG和核因子κB受体激活剂配体(RANKL)。通过连续收集透析液来测量磷酸盐清除情况。
透析前血清磷酸盐浓度是决定透析中磷酸盐清除的关键因素。然而,多元回归分析表明,用多种因素的组合比仅用磷酸盐浓度能更好地解释磷酸盐清除情况。在这个模型中,PTH/OPG比值是一个额外的积极因素,而年龄和维生素D治疗是消极因素。透析前碳酸氢盐高于20 mEq/L 的患者血清磷酸盐水平较高,因此磷酸盐清除率也较高;有趣的是,这些个体在RANKL/OPG方面也存在显著差异。OPG的平均(标准差)水平显著高于健康人群(16.2(12.5)pmol/L);这些值与年龄相关(r = 0.4,P<0.04)。血清RANKL的平均水平(1.03(1.02)pmol/L)在正常个体范围内。
透析中磷酸盐清除与透析前血浆磷酸盐水平有着至关重要的直接关系。然而,使用由血清磷酸盐、PTH/OPG、年龄和维生素D给药之间的相互作用所定义的更复杂关系,能更精确地解释磷酸盐清除现象。首次报道了HD患者的血清RANKL水平,且与正常人群无异。